focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,812.50
Bid: 1,700.00
Ask: 1,820.00
Change: 0.00 (0.00%)
Spread: 120.00 (7.059%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,812.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BUZZ-U.S. STOCKS ON THE MOVE-Silicon Image, Tetraphase, Agenus

Thu, 18th Dec 2014 14:08

(For faster updates on individual market-movers, Eikon usersplease use search string "STXBZ US"; for the Day Aheadnewsletter, http://link.reuters.com/mex49s; for the Morning NewsCall newsletter, http://link.reuters.com/nex49s)U.S. stock index futures surged on Thursday, putting the S&P 500on track to extend gains from the prior session, as oil pricesshowed hints of stabilizing and ahead of data on the labormarket. U.S. stock index e-mini futures were up on Thursday: DowJones industrial average futures were up 1.28 percent at17,576, S&P 500 futures were up 1.29 percent at 2,040.25and Nasdaq 100 futures were up 1.40 percent at 4,221.

** SILICON IMAGE INC, Wednesday close $6.74, -24.78pct premarket

The chipmaker said it expects revenue to fall 10 percent in2015 due to fewer mobile design wins from one its largestcustomers.

** TETRAPHASE PHARMACEUTICALS INC, Wednesday close$33.19, +15.40 pct premarket

The drug developer said its antibiotic to treat complicatedintra-abdominal infections was as effective as Merck & Co Inc's ertapenem in a late-stage study.

** DUNKIN' BRANDS GROUP INC, Wednesday close$46.22, -7.38 pct premarket

The Dunkin' Donuts restaurant operator cut its 2015 forecastfor same-store sales growth in the United States and operatingincome growth, citing slowing sales of packaged coffee in itsrestaurants.

** AGENUS INC, Wednesday close $3.35, +14.33 pctpremarket

The biotechnology company said an experimental vaccineagainst shingles by its partner GlaxoSmithKline met itsgoal in a late-stage study. Agenus will get royalties onpotential commercial sales of the vacine.

** JABIL CIRCUIT INC, Wednesday close $20.07, +6.18pct premarket

The company, which makes phone casings for Apple Inc, forecasts second-quarter revenue above estimates,boosted by strong sales of iPhone 6 and 6 Plus. The companyforecast second quarter core earnings of 39-50 cents per share,higher than analysts' average estimate of profit of 38 cents pershare.

** ORACLE INC, Wednesday close $41.16, +6.00 pctpremarket

The software maker reported a 3.5 percent increase inquarterly revenue on Wednesday, beating Wall Street'sexpectations, as sales at its closely watched cloud servicesbusiness rose 45 percent.

** WINNEBAGO INDUSTRIES INC, Wednesday close$23.85, -6.92 pct premarket

The maker of motorhomes and camping trailers reported alower-than-expected profit as a shortage of workers at a keyplant in rural Iowa and trouble sourcing key components fromsuppliers stymied production of the company's recreationalvehicles.

** ACCENTURE PLC, Wednesday close $85.3, +3.17 pctpremarket

The consulting and outsourcing company raised its revenueforecast for fiscal 2015 after contract wins helped the companypost better-than-expected first-quarter earnings and revenue. The company said it expects revenue growth of 5-8 percent forthe year ending August on a local currency basis, up from the4-7 percent growth it had estimated earlier.

** RITE AID CORP, Wednesday close $6.06, +13.37 pctpremarket

The U.S. drugstore chain's quarterly profit jumped 46.5percent as higher sales of prescription drugs boosted same-storesales. The company's net income rose to $104.9 million, or 10cents per share, in the third quarter ended Nov. 29 from $71.6million, or 4 cents per share, a year earlier.

** AK STEEL HOLDING CORP, Wednesday close$5.56, +10.25 pct premarket

The steel maker said it expects fourth-quarter shipments tojump 37 percent compared with the third quarter, helped byacquisitions and strong demand from auto industry.

** THE PANTRY INC, Wednesday close $35.52, +2.25pct premarket

Canadian convenience store operator Alimentation Couche-TardInc will buy the Kangaroo Express chain operator forabout $861 million to boost its presence in the southeastern andGulf Coast regions. Couche-Tard offered $36.75 per share forPantry, which represents a premium of 3.5 percent to the stock'sWednesday close. Including debt, the deal is valued at $1.7billion. Pantry stock jumped 23 percent on Wednesday after theWall Street Journal reported that the company was nearing a dealto sell itself through an auction.

** NATIONAL BANK OF GREECE, Wednesday close$1.99, -4.02 pct premarket

The largest Greek bank's U.S.-listed shares down inpremarket trading on Thursday after first-round presidentialvote in Greece saw Prime Minister Antonis Samaras lose bylarger-than-expected margin.

** BLACKBERRY LTD, Wednesday close $9.98, +1.90 pctpremarket

The Canadian mobile technology company launched itslong-awaited Classic on Wednesday, a smartphone it hopes willhelp it win back market share and woo those still using olderversions of its physical keyboard devices.

** ZAGG INC, Wednesday close $5.33, up 14.4 pctafter market

The mobile accessories maker raised its full-year net salesforecast to $250 million-$255 million from previous range of$225 million-$235 million. The forecast also beat analysts'average estimate of $232.5 million, according to Thomson ReutersI/B/E/S.

** EXXON MOBIL CORP, Wednesday close $89.02, +1.44pct premarket

** CHEVRON CORP, Wednesday close $106.02, +1.80 pctpremarket

** CONOCOPHILLIPS, Wednesday close $66.94, +2.84 pctpremarket

** CHESAPEAKE ENERGY CORP, Wednesday close$18.68, +3.96 pct premarket

Oil company stocks rise after Brent crude jumps 3.3percent to above $63/bbl, extending a rebound from 5-year lowsthis week as more energy firms cut investment in new production.

** HERTZ GLOBAL HOLDINGS INC, Wednesday close$21.31, +4.27 pct premarket

Carl Icahn, the rental car company's largest shareholder,raised stake in the company to 11.34 percent from 10.77 percent.Icahn revealed an 8.48 percent stake in Hertz in August; he hassince ousted CEO Mark Frissora and won three board seats at thecompany.

** KIRBY CORP, Wednesday close $88.75, +0.28 pctpremarket

The tank bank operator lowered fourth quarter earningsestimate to $1.10-$1.20 per share from $1.30-$1.40 per share.The company also lowered its full year earnings estimate to$4.84 to $4.94 per share from $5.04-$5.14 per share. (Compiled by Anannya Pramanick in Bangalore; Edited by DonSebastian)

More News
1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

Read more
1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

Read more
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more
26 Oct 2023 09:19

TOP NEWS: GSK subsidiary ViiV receives HIV drug approval in China

(Alliance News) - GSK PLC on Thursday said its subsidiary ViiV Healthcare has received marketing authorisation in China for its cabotegravir treatment, marketed as Vocabria.

Read more
26 Oct 2023 07:02

GSK HIV injection regimen gets approval in China

(Sharecast News) - GSK announced on Thursday that its majority-owned HIV specialist subsidiary ViiV has received approval from the National Medical Products Administration (NMPA) of China for an injection regimen.

Read more
25 Oct 2023 16:01

UK earnings, trading statements calendar - next 7 days

Thursday 26 October 
Bank of Ireland Group PLCTrading Statement
Bloomsbury Publishing PLCHalf Year Results
Botswana Diamonds PLCTrading Statement
C&C Group PLCHalf Year Results
e-Therapeutics PLCHalf Year Results
Financials Acquisition CorpTrading Statement
GCP Infrastructure Investments LtdTrading Statement
HarbourVest Global Private Equity LtdHalf Year Results
Hummingbird Resources PLCTrading Statement
Hunting PLCTrading Statement
Inchcape PLCTrading Statement
International Personal Finance PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Renishaw PLCTrading Statement
Standard Chartered PLCQ3 Results
Unilever PLCTrading Statement
WPP PLCTrading Statement
Friday 27 October 
International Consolidated Airlines Group SAQ3 Results
NatWest Group PLCQ3 Results
Monday 30 October 
Airtel Africa PLCHalf Year Results
Computacenter PLCTrading Statement
Glencore PLCTrading Statement
HSBC Holdings PLCQ3 Results
Lok'n Store Group PLCFull Year Results
Pearson PLCTrading Statement
Tuesday 31 October 
BP PLCQ3 Results
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCFull Year Results
Georgia Capital PLCQ3 Results
Grit Real Estate Income Group LtdFull Year Results
RHI Magnesita NVTrading Statement
Spectris PLCQ3 Results
TP ICAP Group PLCTrading Statement
UP Global Sourcing Holdings PLCFull Year Results
Wednesday 1 November 
Asos PLCFull Year Results
Aston Martin Lagonda Global Holdings PLCQ3 Results
Beximco Pharmaceuticals LtdFull Year Results
GSK PLCQ3 Results
Next PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Weir Group PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
25 Oct 2023 09:35

GSK says RSV jab shows promising response in adults aged 50 to 59

(Alliance News) - GSK PLC on Wednesday said a trial found its respiratory syncytial virus vaccine Arexy delivered an immune response in adults aged 50 to 59.

Read more
25 Oct 2023 07:27

GSK hails success in US RSV vaccine trial

(Sharecast News) - Pharma giant GSK has announced positive preliminary results from a trial of its Arexvy vaccine to treatment respiratory syncytial virus (RSV) disease for a younger patient population in the US.

Read more
16 Oct 2023 08:09

TOP NEWS: GSK receives positive EU opinion on Jemperli for cancer

(Alliance News) - GSK PLC on Monday said its monoclonal antibody Jemperli is closer to becoming the first new frontline treatment option in the EU in decades for a certain form of endometrial cancer.

Read more
16 Oct 2023 07:44

LONDON BRIEFING: Hipgnosis pulls interim dividend on lower royalties

(Alliance News) - The FTSE 100 is likely to open higher on Monday, benefitting from higher oil and gas prices, while fears of escalating regional conflict in the Middle East damp risk sentiment elsewhere.

Read more
16 Oct 2023 07:16

GSK nears green light for Jemperli usage in Europe

(Sharecast News) - Pharma giant GSK has announced that European experts recommended the approval of its Jerperli drug for the treatment of a specific type of endometrial cancer - paving the way for marketing authorisation by the continent's regulatory body.

Read more
11 Oct 2023 11:51

GSK settles California Zantac lawsuit

(Sharecast News) - GSK has agreed to settle another lawsuit concerning its discontinued heartburn treatment Zantac, the drugs giant confirmed on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.